254 related articles for article (PubMed ID: 31905933)
1. Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma.
Haberl EM; Pohl R; Rein-Fischboeck L; Feder S; Sinal CJ; Bruckmann A; Hoering M; Krautbauer S; Liebisch G; Buechler C
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905933
[TBL] [Abstract][Full Text] [Related]
2. Chemerin in a Mouse Model of Non-alcoholic Steatohepatitis and Hepatocarcinogenesis.
Haberl EM; Pohl R; Rein-Fischboeck L; Feder S; Sinal CJ; Buechler C
Anticancer Res; 2018 May; 38(5):2649-2657. PubMed ID: 29715085
[TBL] [Abstract][Full Text] [Related]
3. Chemerin Isoform-Specific Effects on Hepatocyte Migration and Immune Cell Inflammation.
Feder S; Bruckmann A; McMullen N; Sinal CJ; Buechler C
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003572
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis.
Pohl R; Eichelberger L; Feder S; Haberl EM; Rein-Fischboeck L; McMullen N; Sinal CJ; Bruckmann A; Weiss TS; Beck M; Höring M; Krautbauer S; Liebisch G; Wiest R; Wanninger J; Buechler C
Mol Cell Biochem; 2022 Aug; 477(8):2059-2071. PubMed ID: 35449483
[TBL] [Abstract][Full Text] [Related]
5. Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation.
Lin Y; Yang X; Liu W; Li B; Yin W; Shi Y; He R
Oncogene; 2017 Jun; 36(25):3599-3608. PubMed ID: 28166197
[TBL] [Abstract][Full Text] [Related]
6. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
7. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
[TBL] [Abstract][Full Text] [Related]
8. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
9. Chemerin causes lipid metabolic imbalance and induces passive lipid accumulation in human hepatoma cell line via the receptor GPR1.
Zhu L; Huang J; Wang Y; Yang Z; Chen X
Life Sci; 2021 Aug; 278():119530. PubMed ID: 33887347
[TBL] [Abstract][Full Text] [Related]
10. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
Lu M; Wu J; He F; Wang XL; Li C; Chen ZN; Bian H
J Mol Histol; 2015 Feb; 46(1):79-91. PubMed ID: 25447507
[TBL] [Abstract][Full Text] [Related]
11. The involvement of iron in chemerin induced cell cycle arrest in human hepatic carcinoma SMMC7721 cells.
Sun P; Wang S; Wang J; Sun J; Peng M; Shi P
Metallomics; 2018 Jun; 10(6):838-845. PubMed ID: 29872820
[TBL] [Abstract][Full Text] [Related]
12. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin 7/19 expression in N-diethylnitrosamine-induced mouse hepatocellular lesions: implications for histogenesis.
Santos NP; Oliveira PA; Arantes-Rodrigues R; Faustino-Rocha AI; Colaço A; Lopes C; Gil da Costa RM
Int J Exp Pathol; 2014 Jun; 95(3):191-8. PubMed ID: 24730441
[TBL] [Abstract][Full Text] [Related]
14. Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis.
Pohl R; Haberl EM; Rein-Fischboeck L; Zimny S; Neumann M; Aslanidis C; Schacherer D; Krautbauer S; Eisinger K; Weiss TS; Buechler C
Eur J Clin Invest; 2017 Jan; 47(1):7-18. PubMed ID: 27797398
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice.
Haberl EM; Pohl R; Rein-Fischboeck L; Höring M; Krautbauer S; Liebisch G; Buechler C
Lipids Health Dis; 2021 Oct; 20(1):135. PubMed ID: 34629057
[TBL] [Abstract][Full Text] [Related]
16. Hepatic chemerin and chemokine-like receptor 1 expression in patients with chronic hepatitis C.
Kukla M; Adamek B; Waluga M; Zalewska-Ziob M; Kasperczyk J; Gabriel A; Mazur W; Sobala-Szczygieł B; Bułdak RJ; Zajęcki W; Kępa L; Ziora K; Żwirska-Korczala K; Wiczkowski A; Hartleb M
Biomed Res Int; 2014; 2014():517820. PubMed ID: 25121101
[TBL] [Abstract][Full Text] [Related]
17. Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma.
Mittenbühler MJ; Sprenger HG; Gruber S; Wunderlich CM; Kern L; Brüning JC; Wunderlich FT
Mol Metab; 2018 Nov; 17():122-133. PubMed ID: 30224299
[TBL] [Abstract][Full Text] [Related]
18. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
19. Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice.
Fuentes-Hernández S; Alarcón-Sánchez BR; Guerrero-Escalera D; Montes-Aparicio AV; Castro-Gil MP; Idelfonso-García OG; Rosas-Madrigal S; Aparicio-Bautista DI; Pérez-Hernández JL; Reyes-Gordillo K; Lakshman MR; Vásquez-Garzón VR; Baltiérrez-Hoyos R; López-González ML; Sierra-Santoyo A; Villa-Treviño S; Pérez-Carreón JI; Arellanes-Robledo J
Toxicol Appl Pharmacol; 2019 Sep; 378():114611. PubMed ID: 31176654
[TBL] [Abstract][Full Text] [Related]
20. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
